Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision

Details for Australian Patent Application No. 2005244149 (hide)

Owner Allergan, Inc.

Inventors Zhang, Kai-Ming; Jackson, Brittany A.; Burke, James; Wheeler, Larry A.; Huang, Glenn; Hughes, Patrick M.; Donn, Rosy S.; Lin, Ton

Agent Davies Collison Cave

Pub. Number AU-A-2005244149

PCT Pub. Number WO2005/110368

Priority 10/836,911 30.04.04 US

Filing date 26 April 2005

Wipo publication date 24 November 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110368 Priority application(s): WO2005/110368

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244151-Compositions for affecting weight loss

2005244146-Apparatus and method for modified horizontal directional drilling assembly